#
About Us
Account
Activity
Add Listing
Add Post
All Groups
Change Password
Contact Us
Create Group
Default User Group
Forgot Password
Forgot Password?
Frequently Asked Questions (FAQ)
Gallery
GD Archive
GD Archive Item
GD Details
Group Item
Group Single
Groups
Home
Job Dashboard
Jobs
Location
Login
Login
Members
Messages Inbox
My Profile
News
Notifications
Portfolio
Post a Job
Profile
Register
Registration
Reset Password
Search page
Search Users
Services
Submit New Blog Post
Terms and Conditions
User Blogs
Users
Users List Item

Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelm

Written by

The pharmaceutical company will give up its ownership rights to the drug and stop a clinical trial that had been aimed at confirming whether it works.

Author: Rebecca Robbins

←What the Fed’s Moves Mean for Mortgages, Credit Cards and Savings

Fox News to Taylor Swift: ‘Don’t Get Involved in Politics!’→

Comments

DOSSIET

Blog
About
FAQs
Authors

Events
Shop
Patterns
Themes

Twenty Twenty-Five

Designed with WordPress

Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelm

Author: Rebecca Robbins

Comments

Leave a Reply Cancel reply

More posts

Southwest Passenger Says She Was Ejected From Flight Based on Her Race

Union Pacific in Talks to Acquire Norfolk Southern

Union Pacific in Talks to Acquire Norfolk Southern

Europe Nears U.S. Trade Deal, but Stands Ready to Retaliate